Solberg A, Grydeland M, Nilsen TS, Storås AH, Davis ID, Greaves N, Anderson S, Fay AP, Chi KN, Enting D, McDermott R, Badal S, Waihenya CG, Popoola A, Lazarus JM, Mateo J, Bjartell A, Omlin A, Odedina F, Ragin C, Mucci LA, IRONMAN investigators, Russnes KM(2026) Correction to: Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry Support Care Cancer, 34(10) DOI 10.1007/s00520-026-11294-6, PubMed 42825937
Solberg A, Grydeland M, Nilsen TS, Storås AH, Davis ID, Greaves N, Anderson S, Fay AP, Chi KN, Enting D, McDermott R, Badal S, Waihenya CG, Popoola A, Lazarus JM, Mateo J, Bjartell A, Omlin A, Odedina F, Ragin C, Mucci LA, Russnes KM, IRONMAN investigators(2026) Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry Support Care Cancer, 34(10) DOI 10.1007/s00520-026-11251-3, PubMed 42771055
Sivanesan S, Ramberg H, Kristiansen T, Thapa SB, Bjøre M, Berge V, Ottosson F, Brennhovd B, Storås AMH, Thorsby PM, Dahl SR, Urbanucci A, Grytli HH, Bjerke L, Taskén KA(2026) Perioperative propranolol during robotic-assisted radical prostatectomy: A randomised, double-blind, placebo-controlled, pilot trial (PeP-RALP) BJUI Compass, 7(9), e70267 DOI 10.1002/bco2.70267, PubMed 42662047